The report said, "Increasing access to direct-to-consumer prescription plans was a central pillar of Trump's "most favored nation" executive order in May, which was intended to reduce U.S. drug prices in parity with other developed countries."
Trump's goal was triggered by the fact Americans pay three times more for brand name prescriptions than do people in other developed countries, the White House has revealed.
No comments:
Post a Comment